Aprea Therapeutics
APRE
APRE
26 hedge funds and large institutions have $3.78M invested in Aprea Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
45% less capital invested
Capital invested by funds: $6.83M → $3.78M (-$3.05M)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$61.4K | |
| 2 | +$3.77K | |
| 3 | +$1.43K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$967 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2 |
Top Sellers
| 1 | -$202K | |
| 2 | -$11.9K | |
| 3 | -$9.08K | |
| 4 |
Morgan Stanley
New York
|
-$8.16K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$6.62K |
